N-Acetyl Semax Amidate
N-Acetyl Semax Amidate is a stabilized version of the Russian neuropeptide Semax, designed to last longer in the body. While direct studies on this exact compound are missing, research on the parent molecule suggests potential benefits for memory, attention, and recovery after brain stress.
N-Acetyl Semax Amidate
Half-Life
Not established
Route
Intranasal (primary), subcutaneous
Typical Dose
Not established
Mechanism / Target
Neuromodulation (BDNF, glutamatergic, GABAergic)
Evidence Level
Preclinical (animal studies, limited human Semax data)
Primary Research Use
Cognitive recovery and nootropic research
Mechanism: Acts as a broad neuromodulator, influencing brain-derived neurotrophic factor (BDNF), glutamate, and GABA systems to support neuronal health and stress adaptation. [source:1][source:6][source:7]
This information is for research only. Not intended for human use.
Overview
N-Acetyl Semax Amidate is a longer-acting variant of Semax, a peptide originally developed in Russia. Semax itself is a synthetic piece of the hormone ACTH, modified to resist breakdown . Research on Semax shows it can improve memory, attention, and recovery after brain injury in animal studies, and it has been used clinically in stroke recovery .
N-Acetyl Semax Amidate was created by adding two chemical caps that are thought to further slow its degradation, making it last longer . However, direct published studies on this exact analogue are missing from the literature. Most of what we know comes from work on Semax and from practical experience in nootropic communities . So, the research context for N-Acetyl Semax Amidate is mainly an inference from the stronger evidence base for Semax. That means the effects described below are plausible but not proven specifically for this analogue.
How it works
Research indicates that Semax-class peptides act as neuromodulators, meaning they tweak multiple brain systems rather than hitting a single receptor . One key effect is boosting neurotrophins like BDNF, which support the health and growth of neurons . This is important for learning and recovery after injury. Semax also protects neurons against toxic overactivation, partly by helping manage calcium levels inside the cell .
At the receptor level, Semax has been shown to shift the balance of excitatory (glutamate) and inhibitory (GABA) signaling. In animal studies, regular Semax changed the density of NMDA receptors, which are involved in memory and plasticity, but it did not directly bind to them . It also increased GABA type A receptors, which are calming . So, over time, Semax may help the brain become more resilient to stress and less prone to excitotoxicity.
For N-Acetyl Semax Amidate, the added acetyl and amide groups are expected to slow its breakdown by enzymes in the body, leading to a longer active window . This is based on general peptide chemistry; specific pharmacokinetic studies for this compound are not available.
Documented effects
Animal research with Semax has shown several notable effects on brain function and recovery:
- Memory and learning: In rats with chronic brain ischemia (reduced blood flow), intranasal Semax improved maze performance and memory retention, with benefits appearing by day 3 of treatment .
- Motor function: The same models showed better movement and less neurological deficit when Semax was used, especially when combined with hopantenic acid .
- Stress resilience: In stress-induced depression models, Semax reduced anxiety-like behaviors and normalized stress hormone and immune responses .
- Direct neuroprotection: In cell cultures, Semax protected neurons from damage caused by excess glutamate, a common trigger for cell death in stroke and trauma .
- Eye health: One rat study found that Semax improved retinal blood flow and electrical function in hypertensive eye disease .
However, these findings come from Semax, not the N-acetyl amidate version. The amidate analogue is assumed to produce similar benefits with longer duration, but this hasn't been tested head-to-head. Human evidence is limited to observational use of Semax in stroke recovery and nootropic settings, primarily in Russia . As a research compound, N-Acetyl Semax Amidate's effects remain largely inferred.
Research protocols
Research on N-Acetyl Semax Amidate follows protocols extrapolated from Semax studies and practical use. Most studies on Semax use intranasal administration because it allows the peptide to reach the brain quickly, bypassing the bloodstream . Therefore, intranasal dosing is the primary route in research protocols, though subcutaneous injection is also used.
Common starting doses range from 300 to 900 micrograms (mcg) per day, split into one or two doses. Because the amidate version is expected to last longer, some protocols use a single morning dose to avoid sleep disruption, as Semax can be mildly stimulating . Cycles typically last 10 to 30 days, with many users following a 4 to 6 week cycle followed by an off period. This pattern is based on animal studies where benefits emerged over several days and persisted without continuous dosing .
The interactive protocol timeline above outlines a typical scheme: an initial low-dose phase to assess response, followed by a standard dose phase. Adjustments may be made based on individual factors such as body weight, but no validated weight-based dosing exists.
For researchers considering injectable routes, subcutaneous doses often range from 250 to 1000 mcg daily. However, the supporting literature is thinner for this route; intranasal delivery is better represented in the Semax evidence base.
Initial assessment
Monitor initial response and tolerability.
Standard protocol
Based on community protocols for cognitive support. Adjust timing to avoid sleep disruption.
This information is for research only. Not intended for human use.
Reconstitution and storage
Proper handling is important for peptide stability. N-Acetyl Semax Amidate, like Semax, is susceptible to breakdown by enzymes and should be kept cold and dry before mixing . The unreconstituted powder can be stored in a refrigerator (2 to 8°C) for months or in a freezer (-20°C) for longer periods.
For mixing, bacteriostatic water is typically used if the solution will be used over several days; sterile water is fine for single-use preparations. After adding the water, the vial should be swirled gently, not shaken, until the powder dissolves. Once mixed, the solution must be refrigerated and used within about 4 weeks to ensure potency. Avoid repeated warming and always check for cloudiness or particles before use.
The reconstitution calculator on this page can help determine exact volumes and concentrations. Because the steps are straightforward but the math matters, the interactive tool is the safest way to get precise numbers. Never use tap water or non-sterile solutions; contamination risks infection, especially for injectable use.
Concentration
25 mcg / unit
Draw Volume
10 units (0.1 ml)
Doses Per Vial
20 doses
Total Solution
200 units (2 ml)
This information is for research only. Not intended for human use.
Interactions
No formal drug interaction studies exist for N-Acetyl Semax Amidate, so we base our understanding on Semax's pharmacology. Semax has been shown to affect blood clotting in animal studies, so combining it with anticoagulants or antiplatelet drugs (like aspirin) could increase bleeding risk . This is a moderate theoretical concern.
Semax also modulates neurotransmitter systems, including GABA, glutamate, and dopamine . Using it alongside other cognitive enhancers, stimulants, or sedatives may produce unpredictable results. For example, mixing with caffeine or ADHD medications might increase jitteriness or sleep problems. With calming supplements like magnesium, the interaction is likely mild, but caution is advised.
There is no direct data on peptide-peptide interactions. In practice, Semax is sometimes stacked with Selank for a balanced cognitive effect, and animal studies suggest compatibility . Combining with repair peptides like BPC-157 is considered neutral based on practitioner experience, but no research supports this.
If you take prescription medications, especially for mood, seizures, or blood clotting, consult a specialist before introducing N-Acetyl Semax Amidate in a research context.
Cycling and tolerance
Cycling refers to scheduled periods of use followed by an off period. Because Semax studies show that effects can diminish with continuous exposure, many research protocols use cycles to maintain effectiveness . Typical cycles for N-Acetyl Semax Amidate are 2 to 4 weeks on, followed by 1 to 2 weeks off, though some users prefer a 5-day-on/2-day-off pattern.
Animal research provides a rationale: subchronic Semax alters receptor density in ways that suggest adaptation over time . Taking breaks may allow these systems to reset, preserving the compound's nootropic impact. Signs that a break is needed include reduced focus, irritability, or needing higher doses for the same effect.
There is no evidence of physical withdrawal from stopping Semax, but some subjective rebound fatigue has been noted in community reports. Cycling is therefore a precautionary strategy rather than a medical necessity.
Stacking
In nootropic research, N-Acetyl Semax Amidate is often combined with other compounds to target multiple cognitive pathways. One popular stack pairs it with Selank, a peptide with anxiolytic properties, for a balanced focus-plus-calm effect. Animal studies show that both Semax and Selank normalize stress-related immune changes, suggesting they may work well together .
For memory and neuroplasticity, some researchers add choline sources or racetams. However, because Semax already influences glutamate and acetylcholine systems indirectly, stacking too many glutamatergic agents could lead to overstimulation .
When stacking with metabolic peptides or GLP-1 agonists, no direct interactions are documented. Practical experience suggests that Semax's mild stimulant effect may counteract the fatigue sometimes seen with those compounds.
As always, add only one new compound at a time and monitor for side effects like headache, irritability, or sleep disturbance.
Regulatory status
N-Acetyl Semax Amidate is not FDA-approved, nor is it recognized as a prescription drug in the United States. The parent compound Semax has been used clinically in Russia for stroke and cognitive disorders, but this does not extend to the amidated analogue . In Western countries, it falls into a gray area as an unapproved research peptide.
There is no mention of N-Acetyl Semax Amidate in the corpus regarding DEA scheduling, WADA prohibited lists, or major regulatory approvals. For competitive athletes, the neuroactive nature of the peptide makes it a potential concern under anti-doping rules, even if not explicitly listed.
Practical legality varies by country. In the US, it is generally considered a research chemical, not a consumable supplement. Importation for personal use may be permitted in some jurisdictions, but it carries risk, especially if intended for injection.
Safety and side effects
The safety profile of N-Acetyl Semax Amidate is not directly studied; available information comes from Semax. Overall, Semax has been well-tolerated in short-term human use and animal studies, with no serious adverse events reported in the available trials . However, common side effects noted in community use include headache, overstimulation, irritability, and sleep disruption when dosed late in the day.
Because Semax has shown mild blood-thinning effects in animals, there is a theoretical risk of increased bleeding or bruising, especially when combined with anticoagulants or before surgery . It may also affect immune function and cytokine levels, which could be a concern in autoimmune conditions .
Pregnant or nursing individuals should avoid it due to lack of safety data. Those with bipolar disorder, uncontrolled anxiety, or seizure disorders should use extreme caution, as Semax can increase activation and potentially trigger mania or anxiety.
For most researchers, the main tool for safety monitoring is self-observation: tracking sleep, mood, and any unusual symptoms. Baseline bloodwork (CBC, metabolic panel) is advisable before longer cycles.
Frequently asked questions
Is N-Acetyl Semax Amidate FDA-approved?+
No. There is no FDA approval in the provided corpus for N-Acetyl Semax Amidate, and even the parent compound Semax is described as being used clinically mainly in Russia rather than as a broadly approved Western drug (human clinical/review). Human evidence in the corpus exists for Semax in stroke and cognitive-performance settings, not for the acetyl-amidated analogue specifically (human clinical).
Is intranasal or injectable use better?+
For the parent Semax, intranasal delivery is the best-supported route in the corpus for brain-targeted effects; multiple animal studies used endonasal/intranasal administration and reported improvements in memory, neurologic deficit, and cognitive recovery after ischemic injury (animal). Mechanistic and receptor data also suggest strong CNS engagement after intranasal dosing, including hippocampal and cortical receptor changes (mechanistic/animal).
For N-Acetyl Semax Amidate specifically, direct route-comparison data are not in the corpus. In practice, users choose intranasal for convenience and CNS targeting, and subcutaneous for more predictable systemic delivery when nasal absorption is unreliable (practitioner consensus). Oral use is generally considered poor for peptides because unmodified Semax was developed partly to improve peptide stability versus native ACTH fragments, and peptide degradation remains a core issue (mechanistic).
What is N-Acetyl Semax Amidate usually used for?+
Evidence should be inferred from Semax, not assumed proven for the amidated analogue. Parent Semax has human clinical use in acute ischemic stroke recovery and nootropic applications, with reported acceleration of neurologic recovery and psychophysiologic performance effects (human clinical). Animal work supports memory restoration after chronic brain ischemia, improvement in motor/neurologic deficits, anxiolytic-antidepressant-like effects under stress, and neuroprotection against glutamate toxicity (animal/mechanistic).
Community use of N-Acetyl Semax Amidate is usually for focus, stress resilience, memory encoding, and post-fatigue cognitive support (community protocol).
How long can I take N-Acetyl Semax Amidate?+
There is no direct duration study for N-Acetyl Semax Amidate in the corpus. Parent Semax is commonly studied in short courses: 5 days in human nootropic testing and acute stroke contexts, and 5–20 days in many rodent protocols (human clinical/animal).
Practical use therefore tends to be cyclical rather than continuous: 10–14 days on, then several days to 2 weeks off, or up to 2–4 weeks during a defined cognitive-demand block (community protocol). Continuous long-term daily use has little direct evidence in this corpus.
What dose do people usually use?+
No dosing trials for N-Acetyl Semax Amidate itself are present in the corpus. Parent Semax animal studies used roughly 50–150 mcg/kg/day in several paradigms, including 150 mcg/kg/day intranasally in stress/depression work and 100 mcg/kg/day intraperitoneally in social-stress immunology work (animal). Human Semax in the corpus is described clinically but not with a standardized cross-study mg dose for the analogue you asked about (human clinical).
Common N-Acetyl Semax Amidate use patterns are 300–900 mcg per dose intranasally 1–3 times/day, or 250–750 mcg subcutaneously 1–2 times/day, usually for 10–30 days (community protocol). Start low if combining with other stimulating nootropics (practitioner consensus).
How does N-Acetyl Semax Amidate compare with regular Semax?+
The corpus supports Semax itself, not head-to-head trials versus N-Acetyl Semax Amidate. Semax has documented neuroprotective, nootropic, neuromodulatory, and stress-modulating actions, including effects on calcium homeostasis, GABA/glycine signaling, monoamines, and neurotrophic/inflammatory pathways (mechanistic/review).
N-Acetyl Semax Amidate is generally treated in practice as a potency- and stability-optimized Semax variant, often described as longer-lasting and somewhat “cleaner” or more stimulating at lower doses (community protocol). That is a practitioner inference, not a corpus-supported comparative claim.
What side effects are most likely?+
Direct safety data for N-Acetyl Semax Amidate are absent. For Semax, the corpus overall supports a low side-effect burden relative to many CNS drugs, with human and animal studies emphasizing neurotropic activity without classic hormonal ACTH effects and with broad experimental tolerability (human clinical/review).
In real-world use, the main issues are overstimulation, irritability, headache, nasal irritation with sprays, and sleep disruption if taken late in the day (community protocol). Because Semax can modulate monoaminergic and excitatory/inhibitory signaling, stacking it with stimulants may increase jitteriness in sensitive users (mechanistic).
Can I use N-Acetyl Semax Amidate while pregnant, breastfeeding, or with major psychiatric illness?+
Best answer: avoid unless specifically supervised. The corpus does not provide pregnancy, lactation, or formal psychiatric safety studies for N-Acetyl Semax Amidate or Semax. Although Semax showed anxiolytic/antidepressant-like effects in animal stress models, that does not establish safety in bipolar disorder, psychosis, pregnancy, or breastfeeding (animal).
If someone has bipolar spectrum illness, severe anxiety with activation, or is using multiple psychoactive agents, cautious avoidance is reasonable because Semax-family peptides can alter monoamine and receptor signaling (mechanistic).
Does N-Acetyl Semax Amidate need refrigeration, and can I travel with it?+
Storage data for N-Acetyl Semax Amidate are not in the corpus. Because peptide stability is a known issue in this class, unreconstituted powder is usually kept cold and dry, and reconstituted solutions are commonly refrigerated and used within a limited time window (practitioner consensus). The Semax literature includes substantial discussion of peptide degradation and attempts to improve stability, which supports being conservative with storage (mechanistic).
For travel: lyophilized powder is easier than mixed liquid; keep it protected from heat and light, carry labeling if possible, and avoid leaving mixed solution unrefrigerated for long periods (practitioner consensus).
References
- 1.Physiological effects of Semax, a synthetic analogue of ACTH4–10: Experience and prospects for applicationsZhuikova · 2022
- 2.Semax as a modulator of the psycho-emotional status of rats in an experimental model of depression based on stressMurtalieva, et al. · 2023
- 3.Semax intranasal improve memory deficiency in conditions of experimental chronic brain ischemiaKirchev · 2024
- 4.Motor activity and neurological deficit restoration as the result of combined semax and hopantenic acid influence in experimental chronic brain ischemiaKirchev · 2024
- 5.Cognitive function restoration in rats with chronic brain ischemia using Semax and hopantenic acid comprehensive administrationKirchev · 2023
- 6.Common and Specific Effects of Selank, Noopept, and Semax to Glycine Site of the NMDA Receptor in BALB/c and C57Bl/6 Mice BrainKovalev, et al. · 2023
- 7.Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity.Storozhevykh, et al. · 2007
- 8.Correction of Lipid Metabolism Disorders in Diabetes Mellitus with Peptide DrugsElagina AA, et al. · 2020
- 9.Correction of Experimental Hypertensive Neuroretinopathy with SemaxChernyaeva SS, Lugovskoy SS, Bashuk VV, Pobeda AS, Solovev NV, Shchurovskaya KV, Balabanova AA, Netrebenko AS · 2022
- 10.Influence of Semax on the Level of Pro- and Anti-Inflammatory Cytokines in Conditions of 'Social' StressYasenyavskaya, et al. · 2023
- 11.Subchronic Administration of Noopept and Semax Peptides Increases the Density of Cortical GABAA-Receptors in the Brain of BALB/c MiceVasil’eva, et al. · 2021
- 12.Phenibut, Semax and GIZh-290 Modulate Cortical mGluII Receptors in an Attention Deficit Model in MiceSukhorukova, et al. · 2023
- 13.Modulation of GABA- and glycine-activated ionic currents with semax in isolated cerebral neurons.Sharonova, et al. · 2018
- 14.The use of human induced pluripotent stem cells for testing neuroprotective activity of pharmacological compounds.Novosadova, et al. · 2019
- 15.Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane ModelsSciacca, et al. · 2022
- 16.The experimental study of the immunomodulating action of Semax and Selank on the model of „social” stressYasenyavskaya, et al. · 2022
- 17.Synthetic acth analogue semax displays nootropic-like activity in humansKaplan, et al. · 1996
- 18.Usage of neurospecific peptide substance “semax” in acute period of ischemic insultGusev, et al. · 1997
- 19.Anticoagulation and Antiplatelet Effects of Semax under Conditions of Acute and Chronic Immobilization StressGrigorjeva, et al. · 2010
- 20.Comparative Study of Modulatory Effects of Semax and Primary Proline-Containing Peptides on Hemostatic ReactionsCherkasova, et al. · 2001
- 21.Phenibut, Semax, and GIZh-290 Modulate Cortical mGluII Receptors in an Attention Deficit Model in MiceSukhorukova, et al. · 2023
- 22.Semax as a Universal Drug for Therapy and ResearchKoroleva, et al. · 2018
- 23.An integrated approach to study the molecular aspects of regulatory peptides biological mechanismVyunova, et al. · 2019
- 24.Stability of Semax acetyl to proteolysis in various biological mediaShevchenko, et al. · 2013
- 25.The use of phospholipid nanoparticles for increasing Semax resistance in various proteolytic biological mediaShevchenko, et al. · 2009
- 26.Degradation of ACTH/MSH(4–10) and its synthetic analog semax by rat serum enzymes: An inhibitor studyPotaman, et al. · 1993
- 27.N-terminal degradation of ACTH(4–10) and its synthetic analog semax by the rat blood enzymesPotaman, et al. · 1991
- 28.Selank and semax as potential hepatoprotectors in medical treatment of tuberculosisPetrovsky, et al. · 2019
- 29.The efficacy of semax in the tretament of patients at different stages of ischemic strokeGusev, et al. · 2018
- 30.Relationship between therapeutic effect of the peptide preparation semax and severity of brain ischemiaKhugaeva, et al. · 1997
Last reviewed on Jun 22, 2026
Have more questions about N-Acetyl Semax Amidate?
Ask ChatPEP for protocols, stacking, and cited research tailored to your goals.